期刊文献+

新疆维吾尔族慢性肺源性心脏病患者血浆BNP水平的变化研究

Change Research of plasma Brain Natriuretic Peptide Level in Uyghur Patients with Chronic Pulmonary Heart Disease in Xinjiang
暂未订购
导出
摘要 目的:探讨检测新疆维吾尔族慢性肺源性心脏病(CPHD)患者血浆B型脑钠肽(BNP)水平的临床意义。方法:2011年1月~2012年6月在我种住院治疗维吾尔族CPHD患者51例,根据纽约心脏病协会(NYHA)分级标准分为心功能Ⅰ级组(n=16)、心功能Ⅱ级组(n=14)、心功能Ⅲ-Ⅳ级组(n=21),以单纯COPD维吾尔族患者15例为对照。用免疫荧光法检测血浆BNP浓度,超声心动图检测右室舒张末期内径(RVD)、肺动脉舒张期末期内径(PAD)、肺动脉收缩压(PAP)等。结果:随着NYHA分级的增加,血浆BNP水平随之上升,其中NYHA心功能Ⅱ-Ⅳ级患者BNP水平明显高于心功能I级或单纯COPD患者(P<0.05)。并且维吾尔族CPHD,患者BNP水平与RVD(r=0.293,P=0.017)、PAD(r=0.258,P=0.036)、PAP(r=0.410,P=0.001)成:正相关。结论:维吾尔族CPHD患者血浆BNP水平与心衰程度、心超检测结果等具有较好的相关,可以作为少数民族地区比较简便及准确的评估、随访病情的指标之一。 Objective To investigate the changes of the levels of plasma brain natriuretic peptide (BNP) in uyghur patients with chronic pulmonary heart disease (CPHD) in Xinjiang. Methods Plasma BNP levels were detected in 51 uyghur patients with CPHD who adiministrated into our hospital from 2011 Jan to 2012 Jun, and compared with those of simple COPDuyghur patients (n=15). CPHD patients were divided to NYHA I (n=16), NYHA II (n=14) and NY- HA III-IV (n=21) groups. BNP was measured by immunofluorescence and Cardiac function was evaluated by ultra- sonography. Results the BNP level increased with the NYHA class, NYHA II-IV groups had significantly higher BNP levels than simple COPD or NYHA I group (P 〈0.05). Uyghur CPHD patients BNP levels are positively correlated with right ventricular diameter (r=0.293, P=0. 017), pulmonary artery diameter (r = 0.258, P=0. 036) and pulmonary artery pressure (r=-0.410, P=0.001). Conclusions BNP level may indicate the symptom and the degree of cardiac dys- function in uyghur CPHD patients, it can be used to help clinical evaluation and treatment of uyghur CPHD.
出处 《新疆医学》 2013年第1期46-49,共4页 Xinjiang Medical Journal
关键词 维吾尔族 慢性肺源性心脏病 B型脑钠肽 Uyghur Chronic pulmonary heart disease Brain natriuretic peptide
  • 相关文献

参考文献7

二级参考文献19

  • 1王家宏,黄永麟.脑钠肽在心力衰竭诊治中的应用进展[J].中国实用内科杂志,2005,25(7):657-658. 被引量:21
  • 2王坤,赵蕾,郭艳英,沙根德克,徐翀,敖由特,宋涛,格尔莉,何秉贤.新疆多民族地区中老年脉压与心血管危险因素的分析[J].中国老年学杂志,2006,26(7):896-898. 被引量:3
  • 3王陇德.中国结核病控制现状及展望[J].中华结核和呼吸杂志,2006,29(8):505-506. 被引量:120
  • 4中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺病诊治指南.中华结核和呼吸杂志,2007,30(8):8-17.
  • 5陈灏珠.实用内科学.12版.北京:人民卫生出版社,2006.
  • 6Burgel PR. Antibiotics for acute exacerbations of chronic obstructive pulmonary disease ( COPD ). Med Mal Infect, 2006,11 : 706- 717.
  • 7刘大伟.实用重症医学.北京:人民卫生出版社,2010:510—514.
  • 8Sánchez-Marteles M,Cecilio-Irazola A,Va?ó-Sanchis D,et al.NT-proBNP in chronic obstructive pulmonary disease patients.An Sist Sanit Navar,2009 32(2):235-241.
  • 9Yetkin O,Aksoy Y,Turhan H,et al.Value of plasma BNP levels as a prognostic marker in lung and heart disorders.Tuberk Toraks,2007,55(3):225-230.
  • 10Hill NS,Klinger JR,Warburton RR,et al.Brain natriuretic peptide:possible role in modulation of hypoxic pulmonary hypertension.Am J Physiol,2004,266(1):308-315.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部